Ethan Meltzer1, Peter V Sguigna1, Adnan Subei2, Shin Beh1, Eric Kildebeck3, Darrel Conger1, Amy Conger1, Marlen Lucero4, Benjamin S Frohman4, Ashley N Frohman4, Shiv Saidha5, Steven Galetta6, Peter A Calabresi5, Robert Rennaker7, Teresa C Frohman1, Randy H Kardon8, Laura J Balcer9, Elliot M Frohman10. 1. Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas. 2. Department of Neurology, Michigan State University, East Lansing. 3. Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas3Center for Engineering Innovation, University of Texas at Dallas. 4. Student, Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas. 5. Department of Neurology, Johns Hopkins Hospital, Baltimore, Maryland. 6. Department of Neurology, Population Health, New York University School of Medicine, New York. 7. Department of Bioengineering, University of Texas at Dallas. 8. Department of Ophthalmology, University of Iowa, Iowa City9Iowa City Veterans Affairs Center for Prevention and Treatment of Visual Loss, Iowa City. 9. Department of Neurology, Population Health, New York University School of Medicine, New York10Department of Ophthalmology, New York University School of Medicine, New York. 10. Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas7Department of Bioengineering, University of Texas at Dallas11Department of Ophthalmology, University of Texas Southwestern Medical Center at Dallas.
Abstract
Importance: A neurophysiologic signature of the melanopsin-mediated persistent constriction phase of the pupillary light reflex may represent a surrogate biomarker for the integrity of the retinohypothalamic tract, with potential utility for investigating alterations in homeostatic mechanisms associated with brain disorders and implications for identifying new treatments. Objective: To characterize abnormalities of retinal architecture in patients with multiple sclerosis (MS) and corresponding alterations in the melanopsin-mediated sustained pupillary constriction response. Design, Setting, and Participants: The case-control study was an experimental assessment of various stimulus-induced pupillary response characteristics and was conducted at a university clinical center for MS from September 6, 2012, to February 2015. Twenty-four patients with MS (48 eyes) and 15 individuals serving as controls (30 eyes) participated. The melanopsin-mediated, sustained pupillary constriction phase response following cessation of a blue light stimulus was compared with the photoreceptor-mediated pupillary constriction phase response following cessation of a red light stimulus. Optical coherence tomography was used to characterize the association between pupillary response characteristics and alterations in retinal architecture, specifically, the thickness of the retinal ganglion cell layer and inner plexiform layer (GCL + IPL). Main Outcomes and Measures: Association of pupillary response characteristics with alterations in retinal architecture. Results: Of 24 patients with MS included in the analysis, 17 were women (71%); mean (SD) age was 47 (11) years. Compared with eyes from individuals with MS who had normal optical coherence tomography-derived measures of retinal GCL + IPL thickness, eyes of patients who had GCL + IPL thickness reductions to less than the first percentile exhibited a correspondingly significant attenuation of the melanopsin-mediated sustained pupillary response (mean [SD] pupillary diameter ratios at a point in time, 0.18 [0.1] vs 0.33 [0.09]; P < .001, generalized estimating equation models accounting for age and within-patient intereye correlations). Conclusions and Relevance: In this case-control study, attenuation of the melanopsin-mediated sustained pupillary constriction response was significantly associated with thinning of the GCL + IPL sector of the retina in the eyes of patients with MS, particularly those with a history of acute optic neuritis. Melanopsin-containing ganglion cells in the retina represent, at least in part, the composition of the retinohypothalamic tract. As such, our findings may signify the ability to elucidate a putative surrogate neurophysiologic signature that correlates with a constellation of homeostatic mechanisms in both health and illness.
Importance: A neurophysiologic signature of the melanopsin-mediated persistent constriction phase of the pupillary light reflex may represent a surrogate biomarker for the integrity of the retinohypothalamic tract, with potential utility for investigating alterations in homeostatic mechanisms associated with brain disorders and implications for identifying new treatments. Objective: To characterize abnormalities of retinal architecture in patients with multiple sclerosis (MS) and corresponding alterations in the melanopsin-mediated sustained pupillary constriction response. Design, Setting, and Participants: The case-control study was an experimental assessment of various stimulus-induced pupillary response characteristics and was conducted at a university clinical center for MS from September 6, 2012, to February 2015. Twenty-four patients with MS (48 eyes) and 15 individuals serving as controls (30 eyes) participated. The melanopsin-mediated, sustained pupillary constriction phase response following cessation of a blue light stimulus was compared with the photoreceptor-mediated pupillary constriction phase response following cessation of a red light stimulus. Optical coherence tomography was used to characterize the association between pupillary response characteristics and alterations in retinal architecture, specifically, the thickness of the retinal ganglion cell layer and inner plexiform layer (GCL + IPL). Main Outcomes and Measures: Association of pupillary response characteristics with alterations in retinal architecture. Results: Of 24 patients with MS included in the analysis, 17 were women (71%); mean (SD) age was 47 (11) years. Compared with eyes from individuals with MS who had normal optical coherence tomography-derived measures of retinal GCL + IPL thickness, eyes of patients who had GCL + IPL thickness reductions to less than the first percentile exhibited a correspondingly significant attenuation of the melanopsin-mediated sustained pupillary response (mean [SD] pupillary diameter ratios at a point in time, 0.18 [0.1] vs 0.33 [0.09]; P < .001, generalized estimating equation models accounting for age and within-patient intereye correlations). Conclusions and Relevance: In this case-control study, attenuation of the melanopsin-mediated sustained pupillary constriction response was significantly associated with thinning of the GCL + IPL sector of the retina in the eyes of patients with MS, particularly those with a history of acute optic neuritis. Melanopsin-containing ganglion cells in the retina represent, at least in part, the composition of the retinohypothalamic tract. As such, our findings may signify the ability to elucidate a putative surrogate neurophysiologic signature that correlates with a constellation of homeostatic mechanisms in both health and illness.
Authors: A R Salter; A Conger; T C Frohman; R Zivadinov; E Eggenberger; P Calabresi; G Cutter; L Balcer; E M Frohman Journal: Mult Scler Date: 2008-12-17 Impact factor: 6.312
Authors: Dennis M Dacey; Hsi-Wen Liao; Beth B Peterson; Farrel R Robinson; Vivianne C Smith; Joel Pokorny; King-Wai Yau; Paul D Gamlin Journal: Nature Date: 2005-02-17 Impact factor: 49.962
Authors: Xiaofei Yu; Darcy Rollins; Kelly A Ruhn; Jeremy J Stubblefield; Carla B Green; Masaki Kashiwada; Paul B Rothman; Joseph S Takahashi; Lora V Hooper Journal: Science Date: 2013-11-08 Impact factor: 47.728
Authors: Carolina P B Gracitelli; Gloria Liliana Duque-Chica; Marina Roizenblatt; Ana Laura de Araújo Moura; Balazs V Nagy; Geraldine Ragot de Melo; Paula Delegrego Borba; Sérgio H Teixeira; Sergio Tufik; Dora Fix Ventura; Augusto Paranhos Journal: Ophthalmology Date: 2015-04-07 Impact factor: 12.079
Authors: Carina Kelbsch; Torsten Strasser; Yanjun Chen; Beatrix Feigl; Paul D Gamlin; Randy Kardon; Tobias Peters; Kathryn A Roecklein; Stuart R Steinhauer; Elemer Szabadi; Andrew J Zele; Helmut Wilhelm; Barbara J Wilhelm Journal: Front Neurol Date: 2019-02-22 Impact factor: 4.003
Authors: Stewart Thompson; Frederick R Blodi; Demelza R Larson; Michael G Anderson; Steven F Stasheff Journal: Invest Ophthalmol Vis Sci Date: 2019-05-01 Impact factor: 4.799
Authors: Harrison McAdams; Aleksandra Igdalova; Manuel Spitschan; David H Brainard; Geoffrey K Aguirre Journal: Invest Ophthalmol Vis Sci Date: 2018-11-01 Impact factor: 4.799